1. Targeting MCL-1 protein to treat cancer: opportunities and challenges
   Shady I. Tantawy et al, 2023, Frontiers in Oncology CrossRef
2. TRAIL-induced apoptosis of hepatocellular carcinoma cells isaugmented by targeted therapies
   Bruno Christian Koehler et al, 2009, World Journal of Gastroenterology CrossRef
3. Natural bioactive compounds and STAT3 against hepatocellular carcinoma: An update
   Suryaa Manoharan et al, 2024, Life Sciences CrossRef
4. Regulation of human Mcl-1 by a divergently-expressed antisense transcript
   S.M. Ali Hosseini Rad et al, 2020, Gene CrossRef
5. Sorafenib Blocks the RAF/MEK/ERK Pathway, Inhibits Tumor Angiogenesis, and Induces Tumor Cell Apoptosis in Hepatocellular Carcinoma Model PLC/PRF/5
   Li Liu et al, 2006, Cancer Research CrossRef
6. Down-Regulation of Mcl-1 by Small Interfering RNA Sensitizes Resistant Melanoma Cells to Fas-Mediated Apoptosis
   Nizar Chetoui et al, 2008, Molecular Cancer Research CrossRef
7. Targeting BET Proteins With a PROTAC Molecule Elicits Potent Anticancer Activity in HCC Cells
   Huapeng Zhang et al, 2020, Frontiers in Oncology CrossRef
8. Cyclooxygenase-2 Inhibition Induces Apoptosis Signaling via Death Receptors and Mitochondria in Hepatocellular Carcinoma
   Michael A. Kern et al, 2006, Cancer Research CrossRef
9. Bcl-xL and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells
   Henning Schulze-Bergkamen et al, 2008, World Journal of Gastroenterology CrossRef
10. Sensitization effect of kaempferol from persimmon leaves on HepG2 hepatoma cells with ABT-199 resistance and its molecular mechanisms
    Li Chen et al, 2022, Frontiers in Pharmacology CrossRef